DE69936464D1 - Gp120-mutanten und deren biologische verwendungen - Google Patents

Gp120-mutanten und deren biologische verwendungen

Info

Publication number
DE69936464D1
DE69936464D1 DE69936464T DE69936464T DE69936464D1 DE 69936464 D1 DE69936464 D1 DE 69936464D1 DE 69936464 T DE69936464 T DE 69936464T DE 69936464 T DE69936464 T DE 69936464T DE 69936464 D1 DE69936464 D1 DE 69936464D1
Authority
DE
Germany
Prior art keywords
mutants
biological uses
hxbc2
hiv
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69936464T
Other languages
English (en)
Other versions
DE69936464T2 (de
Inventor
Francisco Veas
Martine Cerutti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Application granted granted Critical
Publication of DE69936464D1 publication Critical patent/DE69936464D1/de
Publication of DE69936464T2 publication Critical patent/DE69936464T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69936464T 1998-11-27 1999-11-29 Gp120-mutanten und deren biologische verwendungen Expired - Lifetime DE69936464T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9814997A FR2786488B1 (fr) 1998-11-27 1998-11-27 Mutants de la gp120 et leurs applications biologiques
FR9814997 1998-11-27
PCT/FR1999/002949 WO2000032786A1 (fr) 1998-11-27 1999-11-29 MUTANTS DE LA gp120 ET LEURS APPLICATIONS BIOLOGIQUES

Publications (2)

Publication Number Publication Date
DE69936464D1 true DE69936464D1 (de) 2007-08-16
DE69936464T2 DE69936464T2 (de) 2008-03-13

Family

ID=9533301

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69936464T Expired - Lifetime DE69936464T2 (de) 1998-11-27 1999-11-29 Gp120-mutanten und deren biologische verwendungen

Country Status (8)

Country Link
US (1) US7078038B1 (de)
EP (1) EP1159427B1 (de)
JP (1) JP4489299B2 (de)
AT (1) ATE366258T1 (de)
CA (1) CA2352603C (de)
DE (1) DE69936464T2 (de)
FR (1) FR2786488B1 (de)
WO (1) WO2000032786A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013279456A1 (en) * 2012-06-18 2014-12-18 Glaxosmithkline Biologicals Sa Stabilized gp120

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002568A1 (en) * 1988-09-13 1990-03-22 Chiron Corporation Hiv-1 envelope muteins lacking hypervariable domains
US20030104577A1 (en) * 1997-02-07 2003-06-05 Uc Regents HIV capsid assembly-associated compositions and method

Also Published As

Publication number Publication date
JP4489299B2 (ja) 2010-06-23
EP1159427B1 (de) 2007-07-04
DE69936464T2 (de) 2008-03-13
US7078038B1 (en) 2006-07-18
ATE366258T1 (de) 2007-07-15
FR2786488B1 (fr) 2003-04-25
EP1159427A1 (de) 2001-12-05
WO2000032786A1 (fr) 2000-06-08
CA2352603A1 (fr) 2000-06-08
FR2786488A1 (fr) 2000-06-02
JP2002542146A (ja) 2002-12-10
CA2352603C (fr) 2012-03-20

Similar Documents

Publication Publication Date Title
ES2078255T3 (es) Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16.
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
SI0887427T1 (sl) Pomnozevanje in detekcija HIV-1 in/ali HIV-2
EP0713530A4 (de) Hohe expressionsrate, reinigung und wiederfaltung vom gruppe b porin proteinen der äusseren membran von neisseria meningitis
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
ES2192620T3 (es) Polipeptido receptor de il-13.
DE60037450D1 (de) Funf-helix protein
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
DE69024965T2 (de) Dehydrodidemnin b
ATE519500T1 (de) Mutanten von hüllglykoproteinen des human immunodeficiency virus und deren verwendung
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
MX9708426A (es) Polipeptido hk2 de variante estable.
ATE366258T1 (de) Gp120-mutanten und deren biologische verwendungen
PT975783E (pt) "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas"
DE59105636D1 (de) Expression von HIV1- und 2- Polypeptiden und deren Verwendung.
WO2000027880A3 (en) Rantes-derived peptides with anti-hiv activity
DE69832197D1 (de) Rantes mutanten und deren therapeutische verwendungen
EP0311108A3 (de) Anti-HIV-aktive 3'-Azido-2,6-diaminopurine-2',3'-dideoxyriboside
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
FI960839A0 (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
DE68901361D1 (de) Anorexigenische und hypotensive peptide.
AU7614798A (en) High level expression, purification and refolding of the Neisseria meningitidis outer membrane group B porin proteins
ECSP982804A (es) Beta- lipotropina y usos de la misma

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: BOCKHORNI & KOLLEGEN, 80687 MUENCHEN

8364 No opposition during term of opposition